[1] Uiterwijk A, Koehler P J. A history of acute bacterial meningitis[J]. J Hist Neurosci. 2012, 21(3): 293-313.
[2] Viallon A, Botelho-nevers E, Zeni F. Clinical decision rules for acute bacterial meningitis: current insights [J]. Open access emergency medicine, 2016, 8: 7-16.
[3] Li Y, Yin Z, Shao Z, et al. Population-based surveillance for bacterial meningitis in China, September 2006-December 2009[J]. Emerg Infect Dis. 2014, 20(1): 61-69.
[4] Molyneux EM, Dube Q, Newberry L. Improving the outcome of bacterial meningitis in newborn infants in Africa: reflections on recent progress [J]. Curr Opin Infect Dis. 2015, 28(3): 215-220.
[5] Zhao Y, Liu J, Zhang J, et al. Imaging Characteristics of Purulent Meningitis Caused by Different Pathogens in Children [J]. Chin comput Med Imag. 2019, 25(2): 106-110.
[6] Jan W, Zimmerman R A, Bilaniuk L T, et al. Diffusion-weighted imaging in acute bacterial meningitis in infancy[J]. Neuroradiology. 2003, 45(9): 634-639.
[7] Okike I O, Ribeiro S, Ramsay M E, et al. Trends in bacterial, mycobacterial, and fungal meningitis in England and Wales 2004-11: an observational study[J]. Lancet Infect Dis. 2014, 14(4): 301-307.
[8] Singhi P, Bansal A, Geeta P, et al. Predictors of long term neurological outcome in bacterial meningitis[J]. Indian J Pediatr. 2007, 74(4): 369-374.
[9] Pelkonen T, Roine I, Monteiro L, et al. Risk factors for death and severe neurological sequelae in childhood bacterial meningitis in sub-Saharan Africa[J]. Clin Infect Dis. 2009, 48(8): 1107-1110.
[10] Levin S N, Lyons J L. Infections of the Nervous System[J]. Am J Med. 2018, 131(1): 25-32.
[11] Stockmann C, Spigarelli M G, Campbell S C, et al. Considerations in the pharmacologic treatment and prevention of neonatal sepsis[J]. Paediatr Drugs. 2014, 16(1): 67-81.
[12] Zhao Z, Yu JL, Zhang HB, et al. Five-year multicenter study of clinical tests of neonatal purulent meningitis [J]. Clin Pediatr (Phila),2018,57(4):389-397.
[13] Karanika M, Vasilopoulou V A, Katsioulis A T, et al. Diagnostic clinical and laboratory findings in response to predetermining bacterial pathogen: data from the Meningitis Registry[J]. PLoS One. 2009, 4(7): e6426.
[14] Bari A. Zeeshan F, Zafar A, Ejaz H, Iftikhar A, Rathore AW. Childhood Acute Bacterial Meningitis: Clinical Spectrum, Bacteriological Profile and Outcome [J]. J Coll Physicians Surg Pak,2016,26(10):822-826.
[15] Lucas MJ, Brouwer MC, van de Beek D. Neurological sequelae of bacterial meningitis [J]. J Infect,2016,73(1):18-27.
[16] Okike I O, Johnson A P, Henderson K L, et al. Incidence, etiology, and outcome of bacterial meningitis in infants aged <90 days in the United kingdom and Republic of Ireland: prospective, enhanced, national population-based surveillance[J]. Clin Infect Dis. 2014, 59(10): e150-e157.
[17] Okike I O, Ladhani S N, Johnson A P, et al. Clinical Characteristics and Risk Factors for Poor Outcome in Infants Less Than 90 Days of Age With Bacterial Meningitis in the United Kingdom and Ireland[J]. Pediatr Infect Dis J. 2018, 37(9): 837-843.
[18] Jo J C, Yoon D H, Kim S, et al. Interim (18)F-FGD PET/CT may not predict the outcome in primary central nervous system lymphoma patients treated with sequential treatment with methotrexate and cytarabine[J]. Ann Hematol. 2017, 96(9): 1509-1515.
[19] Jaremko J L, Moon A S, Kumbla S. Patterns of complications of neonatal and infant meningitis on MRI by organism: a 10 year review[J]. Eur J Radiol. 2011, 80(3): 821-827.
[20] Namani S, Milenkovic Z, Koci B. A prospective study of risk factors for neurological complications in childhood bacterial meningitis[J]. J Pediatr (Rio J). 2013, 89(3): 256-262.
[21] Hsu M H, Hsu J F, Kuo H C, et al. Neurological Complications in Young Infants With Acute Bacterial Meningitis[J]. Front Neurol. 2018, 9: 903.